Juan Luis Reguera-Ortega

6PUBLICATIONS
84CO-AUTHORS
Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2026
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel in 3L+ FL: 3-year update from TRANSCEND FL.

|Jul 11, 2025
Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma.

Mireia Uribe-Herranz, Aina Oliver-Caldés, Neus Martínez-Micaelo

|Nov 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma.

Inés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés

|Sep 14, 2024
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.

Maria-Eva Mingot-Castellano, Juan Luis Reguera-Ortega, Denis Zafra Torres

|Mar 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.

Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta

Pageof 1

Frequent Collaborators

3 joint publications

Aina Oliver-Caldes

3 joint publications

Marta Español-Rego

3 joint publications

Verónica González-Calle

3 joint publications

Luis Gerardo Rodríguez-Lobato